350 related articles for article (PubMed ID: 1469793)
1. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-associated gangliosides in the fish genus Xiphophorus.
Felding-Habermann B; Anders A; Dippold WG; Stallcup WB; Wiegandt H
Cancer Res; 1988 Jun; 48(12):3454-60. PubMed ID: 3370642
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues.
Dippold WG; Dienes HP; Knuth A; Meyer zum Büschenfelde KH
Cancer Res; 1985 Aug; 45(8):3699-705. PubMed ID: 3893688
[TBL] [Abstract][Full Text] [Related]
5. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
6. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies.
Merritt WD; Sztein MB; Taylor B; Reaman GH
Leukemia; 1991 Dec; 5(12):1087-91. PubMed ID: 1774957
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
10. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
11. Detection of GD3 ganglioside in childhood acute lymphoblastic leukemia with monoclonal antibody to GD3: restriction to immunophenotypically defined T-cell disease.
Merritt WD; Sztein MB; Reaman GH
J Cell Biochem; 1988 May; 37(1):11-9. PubMed ID: 3292545
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
13. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies.
Merritt WD; Casper JT; Lauer SJ; Reaman GH
Cancer Res; 1987 Mar; 47(6):1724-30. PubMed ID: 3493067
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells.
Thampoe IJ; Furukawa K; Vellvé E; Lloyd KO
Cancer Res; 1989 Nov; 49(22):6258-64. PubMed ID: 2804971
[TBL] [Abstract][Full Text] [Related]
16. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
19. Alteration in keratinocyte ganglioside content in basal cell carcinomas.
Paller AS; Arnsmeier SL; Robinson JK; Bremer EG
J Invest Dermatol; 1992 Feb; 98(2):226-32. PubMed ID: 1732387
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
